Abstract. The 
aldosterone (TH-aldo) excretion to fludrocortisone administration (0.3 mg q.i.d. for 3 days) was studied. In normal subjects (n = 13) and in patients with essential hypertension (n = 8), urinary TH-aldo decreased to 36 per cent (range 19\ p=n-\ 48) and to 51 per cent (range 33\p=n-\61) of the control value, respectively. Twenty-four patients with primary aldosteronism were studied. Twenty-two of these showed no significant suppression of urinary TH-aldo in that the excretion of TH-aldo was 79 per cent of the control value or more.
Nineteen of these patients were submitted to operation, and an adrenal aldosterone-producing adenoma was disclosed in every single case. Two patients with primary aldosteronism demonstrated a significant suppression of aldosterone production to 62 and 68 per cent, respectively. Adrenal micronodular hyperplasia was verified in one case and suspected in the other. A significant suppression of aldosterone production was observed in 4 of 5 patients with aldosteronism and normal or high plasma renin levels. The combination of low plasma renin and autonomy of aldosterone production offers a high degree of certainty for the presence of an aldosterone-producing adenoma.
The classical findings in primary aldosteronism are hypertension, hypokalaemia, increased aldoste¬ rone production, low plasma renin activity or renin concentration and the presence of an adrenal cor¬ tical adenoma (Conn 1966-67) . However, the aldo¬ sterone production may be within normal limits (Biglieri et al. 1967) , and the plasma renin concen¬ tration may be variable and only intermittently low (Brown et al. 1968 ). Furthermore, identical bio¬ chemical abnormalities have been observed in hy¬ pertensive patients in whom no adrenal adenoma could be found (Davis et al. 1967 ; Katz 1967; Laragh et al. 1967) , and recent reports state that this occurs in 20-50 per cent of patients with high aldosterone/low renin hypertension (Biglieri et al. 1970; Baeretal. 1970; George et al. 1970; Ferriss et al. 1975) . In these cases, the adrenal glands showed bilateral cortical hyperplasia in most cases, but even normal adrenal glands have been de¬ scribed (Baeret. 1970; Ferriss et al. 1975 ). Adrenalectomy, total or subtotal, normalized the blood pressure in a few patients only (0-20 per cent) in spite of normal or absent aldosterone production post-operatively (Biglieri et al. 1970; Baer et al. 1970; George et al. 1970; Ferriss et al. 1975 ).
On the other hand, removal of an aldosteroneproducing adenoma is followed by improvement or disappearance of the hypertension in 60-90 per cent of cases (Conn 1966-67; Biglieri et al. 1970; Baer et al. 1970; George et al. 1970; Ferriss et al. 1975) .
Evaluation of aldosterone production during a mineralocorticoid load has been proposed as a useful tool in the discrimination between various forms of aldosteronism (Biglieri et Normal subjects and patients
In the first part of the study two control groups were investigated.
1. Normal subjects Tetrahydroaldosterone in urine (TH-aldo) was determined in duplicate as previously described (Nielsen et al. 1972 ).
The normal range on a diet with 110 mEq sodium is 30-162 nmol/24 h, and the coefficient of variation (CV) is 12 per cent as determined from 90 duplicate determi¬ nations (Nielsen et al. 1972) . For a ratio between two measurements a and b, each done in duplicate, CV is given by (Colquhoun 1971) :
Accordingly, the coefficient of variation for a ratio be¬ (Bangham et al. 1975 ).
Blood pressure was measured on 3 consecutive mornings in the supine patient. At the follow-up study the operated patients (group 3) were examined after one hour of quite supine rest.
Results
The results are given in Tables 2 and 3 Supine plasma renin concentration (PRC), and excretion of tetrahydroaldosterone (TH-aldo) (Conn 1966-67; Padfield et al. 1975 (Baer et al. 1970; George et al. 1970; Ferriss et al. 1970 (Biglieri et al. 1967 (Biglieri et al. , 1972 Cain et al. 1972; Slaton et al. 1969 ). In their original report Biglieri et al. (1967) demon¬ strated significant suppression of aldosterone ex¬ cretion rate in 2 patients without adenoma. In a larger material (Biglieri et al. 1972) (1967, 1972) defined an abnormal suppression test as a failure to reduce urinary aldosterone levels into the normal range or to depress normal levels, which may be present in the occasional case of primary aldosteronism (Biglieri et al. 1967) . We have evalu¬ ated the response during fludrocortisone loading, using our data on the day-to-day variation and the within-analysis variation. In 2 patients (Nos. 24 and 31) the diurnal excretion of TH-aldo was sup¬ pressed into the normal range, but the change in excretion of TH-aldo did not exceed the limits determined by the analytic and biological variation.
Blood sampling and determination of plasma aldosterone have practical and methodological ad¬ vantages. However, the plasma concentration of aldosterone shows a diurnal variation and several secretory peaks in normal subjects and in patients with aldosterone-producing adenomas or bilateral hyperplasia (Cain et al. 1972; Katzetal. 1972; Kern et al. 1973; Vetter et al. 1974 Vetter et al. , 1978 . The mean value of plasma aldosterone is not suppressed in patients with aldosterone-producing adenomas during fludrocortisone loading (Horton 1969; Padfield et al. 1975; Vetter et al. 1978) (Nielsen et al. 1972 ).
The discrimination between adrenal adenoma and adrenocortical hyperplasia in primary aldoste¬ ronism on the basis of clinical date is impossible (Vetter et al. 1978) . The tendency to more pro¬ nounced biochemical disturbances in patients with adenoma as compared to those with hyperplasia (Baer et al. 1970; Ferriss et al. 1970; Biglieri et al. 1972; Padfield et al. 1975) have formed basis for a useful statistical analysis for prediction of the lesion (Ferriss et al. 1970; Aitchison et al. 1971 ). How¬ ever, this procedure requires a considerable num¬ ber of patients in each group and may be difficult to transfer to other centres due to methodological differences.
In our series of 24 patients with primary aldoste¬ ronism only one case of adrenal hyperplasia was histologically verified and one additional case was suspected. This is a lower frequency than that reported by others (Baer et al. 1970; George et al. 1970; Ferriss et al. 1975; Vetter et al. 1978) . A probable explanation of this discrepancy can be the use of more restrictive criteria for inclusion in our study.
